{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T22:07:05Z","timestamp":1783980425619,"version":"3.55.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"29","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,8,4]]},"DOI":"10.1038\/s41388-026-03850-5","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T09:52:40Z","timestamp":1781517160000},"page":"2914-2931","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Amphiregulin drives EGFR-dependent genome stability in colorectal cancer and represents a targetable vulnerability"],"prefix":"10.1038","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4921-0239","authenticated-orcid":false,"given":"Sun-Ji","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heegyum","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Min","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Man","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7106-1615","authenticated-orcid":false,"given":"Dong-Seok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1547-2580","authenticated-orcid":false,"given":"Eui-Hwan","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"3850_CR1","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","volume":"72","author":"E Morgan","year":"2023","unstructured":"Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag CJ, Laversanne M, et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023;72:338\u201344.","journal-title":"Gut"},{"key":"3850_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/1758834015614530","volume":"8","author":"WA Hammond","year":"2016","unstructured":"Hammond WA, Swaika A, Mody K. Pharmacologic resistance in colorectal cancer: a review. Ther Adv Med Oncol. 2016;8:57\u201384.","journal-title":"Ther Adv Med Oncol"},{"key":"3850_CR3","doi-asserted-by":"publisher","first-page":"6876","DOI":"10.3748\/wjg.v22.i30.6876","volume":"22","author":"T Hu","year":"2016","unstructured":"Hu T, Li Z, Gao CY, Cho CH. Mechanisms of drug resistance in colon cancer and its therapeutic strategies. World J Gastroenterol. 2016;22:6876\u201389.","journal-title":"World J Gastroenterol"},{"key":"3850_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.5306\/wjco.v6.i5.133","volume":"6","author":"B Pabla","year":"2015","unstructured":"Pabla B, Bissonnette M, Konda VJ. Colon cancer and the epidermal growth factor receptor: current treatment paradigms, the importance of diet, and the role of chemoprevention. World J Clin Oncol. 2015;6:133\u201341.","journal-title":"World J Clin Oncol"},{"key":"3850_CR5","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1038\/msb4100014","volume":"1","author":"K Oda","year":"2005","unstructured":"Oda K, Matsuoka Y, Funahashi A, Kitano H. A comprehensive pathway map of epidermal growth factor receptor signaling. Mol Syst Biol. 2005;1:2005\u20130010.","journal-title":"Mol Syst Biol"},{"key":"3850_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1146\/annurev-med-062913-051343","volume":"67","author":"IA Mayer","year":"2016","unstructured":"Mayer IA, Arteaga CL. The PI3K\/AKT pathway as a target for cancer treatment. Annu Rev Med. 2016;67:11\u201328.","journal-title":"Annu Rev Med"},{"key":"3850_CR7","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","volume":"6","author":"Y He","year":"2021","unstructured":"He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, et al. Targeting PI3K\/Akt signal transduction for cancer therapy. Signal Transduct Target Ther. 2021;6:425.","journal-title":"Signal Transduct Target Ther"},{"key":"3850_CR8","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu X, Li J, Fu M, Zhao X, Wang W. The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther. 2021;6:402.","journal-title":"Signal Transduct Target Ther"},{"key":"3850_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/annonc\/mdi057","volume":"16","author":"JP Spano","year":"2005","unstructured":"Spano JP, Fagard R, Soria JC, Rixe O, Khayat D, Milano G. Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectives. Ann Oncol. 2005;16:189\u201394.","journal-title":"Ann Oncol"},{"key":"3850_CR10","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41591-023-02696-8","volume":"30","author":"J Desai","year":"2024","unstructured":"Desai J, Alonso G, Kim SH, Cervantes A, Karasic T, Medina L, et al. Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial. Nat Med. 2024;30:271\u20138.","journal-title":"Nat Med"},{"key":"3850_CR11","first-page":"29","volume":"6","author":"TB Gibson","year":"2006","unstructured":"Gibson TB, Ranganathan A, Grothey A. Randomized phase III trial results of panitumumab, a fully human anti-epidermal growth factor receptor monoclonal antibody, in metastatic colorectal cancer. Clin Colorectal Cancer. 2006;6:29\u201331.","journal-title":"Clin Colorectal Cancer"},{"key":"3850_CR12","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1093\/jnci\/90.11.824","volume":"90","author":"J Rubin Grandis","year":"1998","unstructured":"Rubin Grandis J, Melhem MF, Gooding WE, Day R, Holst VA, et al. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst. 1998;90:824\u201332.","journal-title":"J Natl Cancer Inst"},{"key":"3850_CR13","first-page":"119","volume":"1816","author":"B Busser","year":"2011","unstructured":"Busser B, Sancey L, Brambilla E, Coll JL, Hurbin A. The multiple roles of amphiregulin in human cancer. Biochim Biophys Acta. 2011;1816:119\u201331.","journal-title":"Biochim Biophys Acta"},{"key":"3850_CR14","doi-asserted-by":"crossref","unstructured":"Cheng WL, Feng PH, Lee KY, Chen KY, Sun WL, Van Hiep N, et al. The role of the EREG\/EGFR pathway in tumor progression. Int J Mol Sci. 2021;22:12828.","DOI":"10.3390\/ijms222312828"},{"key":"3850_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.semcdb.2014.01.005","volume":"28","author":"C Berasain","year":"2014","unstructured":"Berasain C, Avila MA. Amphiregulin. Semin Cell Dev Biol. 2014;28:31\u201341.","journal-title":"Semin Cell Dev Biol"},{"key":"3850_CR16","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1002\/jcp.30615","volume":"237","author":"SS Singh","year":"2022","unstructured":"Singh SS, Chauhan SB, Kumar A, Kumar S, Engwerda CR, Sundar S, et al. Amphiregulin in cellular physiology, health, and disease: potential use as a biomarker and therapeutic target. J Cell Physiol. 2022;237:1143\u201356.","journal-title":"J Cell Physiol"},{"key":"3850_CR17","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.cell.2017.09.017","volume":"171","author":"DM Freed","year":"2017","unstructured":"Freed DM, Bessman NJ, Kiyatkin A, Salazar-Cavazos E, Byrne PO, Moore JO, et al. EGFR ligands differentially stabilize receptor dimers to specify signaling kinetics. Cell. 2017;171:683\u201395.e618.","journal-title":"Cell"},{"key":"3850_CR18","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1002\/ijc.34254","volume":"151","author":"F Seefried","year":"2022","unstructured":"Seefried F, Haller L, Fukuda S, Thongmao A, Schneider N, Utikal J, et al. Nuclear AREG affects a low-proliferative phenotype and contributes to drug resistance of melanoma. Int J Cancer. 2022;151:2244\u201364.","journal-title":"Int J Cancer"},{"key":"3850_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12929-025-01119-9","volume":"32","author":"C Tito","year":"2025","unstructured":"Tito C, Masciarelli S, Colotti G, Fazi F. EGF receptor in organ development, tissue homeostasis and regeneration. J Biomed Sci. 2025;32:24.","journal-title":"J Biomed Sci"},{"key":"3850_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13027","volume":"18","author":"Q Xu","year":"2019","unstructured":"Xu Q, Long Q, Zhu D, Fu D, Zhang B, Han L, et al. Targeting amphiregulin (AREG) derived from senescent stromal cells diminishes cancer resistance and averts programmed cell death 1 ligand (PD-L1)-mediated immunosuppression. Aging Cell. 2019;18:e13027.","journal-title":"Aging Cell"},{"key":"3850_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.152576","volume":"215","author":"J Jiang","year":"2019","unstructured":"Jiang J, Zhao W, Tang Q, Wang B, Li X, Feng Z. Overexpression of amphiregulin promoted malignant progression in gastric cancer. Pathol Res Pract. 2019;215:152576.","journal-title":"Pathol Res Pract"},{"key":"3850_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-03197-9","volume":"11","author":"SA Kim","year":"2021","unstructured":"Kim SA, Park H, Kim KJ, Kim JW, Sung JH, Nam M, et al. Amphiregulin can predict treatment resistance to palliative first-line cetuximab plus FOLFIRI chemotherapy in patients with RAS wild-type metastatic colorectal cancer. Sci Rep. 2021;11:23803.","journal-title":"Sci Rep"},{"key":"3850_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.semcancer.2017.06.001","volume":"45","author":"J Huynh","year":"2017","unstructured":"Huynh J, Etemadi N, Hollande F, Ernst M, Buchert M. The JAK\/STAT3 axis: a comprehensive drug target for solid malignancies. Semin Cancer Biol. 2017;45:13\u201322.","journal-title":"Semin Cancer Biol"},{"key":"3850_CR24","first-page":"1558","volume":"43","author":"L Wang","year":"2020","unstructured":"Wang L, Wang L, Zhang H, Lu J, Zhang Z, Wu H, et al. AREG mediates the epithelial\u2011mesenchymal transition in pancreatic cancer cells via the EGFR\/ERK\/NF\u2011kappaB signalling pathway. Oncol Rep. 2020;43:1558\u201368.","journal-title":"Oncol Rep"},{"key":"3850_CR25","doi-asserted-by":"publisher","first-page":"6235","DOI":"10.1158\/0008-5472.CAN-18-0634","volume":"78","author":"NS Nagathihalli","year":"2018","unstructured":"Nagathihalli NS, Castellanos JA, Lamichhane P, Messaggio F, Shi C, Dai X, et al. Inverse correlation of STAT3 and MEK signaling mediates resistance to RAS pathway inhibition in pancreatic cancer. Cancer Res. 2018;78:6235\u201346.","journal-title":"Cancer Res"},{"key":"3850_CR26","doi-asserted-by":"publisher","first-page":"26178","DOI":"10.1074\/jbc.M114.586826","volume":"289","author":"JL Macdonald-Obermann","year":"2014","unstructured":"Macdonald-Obermann JL, Pike LJ. Different epidermal growth factor (EGF) receptor ligands show distinct kinetics and biased or partial agonism for homodimer and heterodimer formation. J Biol Chem. 2014;289:26178\u201388.","journal-title":"J Biol Chem"},{"key":"3850_CR27","doi-asserted-by":"publisher","first-page":"8900","DOI":"10.1074\/jbc.274.13.8900","volume":"274","author":"L Wong","year":"1999","unstructured":"Wong L, Deb TB, Thompson SA, Wells A, Johnson GR. A differential requirement for the COOH-terminal region of the epidermal growth factor (EGF) receptor in amphiregulin and EGF mitogenic signaling. J Biol Chem. 1999;274:8900\u20139.","journal-title":"J Biol Chem"},{"key":"3850_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112377","volume":"42","author":"I Steiner","year":"2023","unstructured":"Steiner I, Flores-Tellez T, Mevel R, Ali A, Wang P, Schofield P, et al. Autocrine activation of MAPK signaling mediates intrinsic tolerance to androgen deprivation in LY6D prostate cancer cells. Cell Rep. 2023;42:112377.","journal-title":"Cell Rep"},{"key":"3850_CR29","first-page":"1","volume":"52","author":"YW Huang","year":"2019","unstructured":"Huang YW, Tsai HC, Wang SW, Kuo SJ, Fong YC, Tang CH. Amphiregulin promotes vascular endothelial growth factor-C expression and lymphangiogenesis through STAT3 activation in human chondrosarcoma cells. Cell Physiol Biochem. 2019;52:1\u201315.","journal-title":"Cell Physiol Biochem"},{"key":"3850_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26806-7","volume":"12","author":"SY Liu","year":"2021","unstructured":"Liu SY, Bao H, Wang Q, Mao WM, Chen Y, Tong X, et al. Genomic signatures define three subtypes of EGFR-mutant stage II-III non-small-cell lung cancer with distinct adjuvant therapy outcomes. Nat Commun. 2021;12:6450.","journal-title":"Nat Commun"},{"key":"3850_CR31","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/mt.2009.226","volume":"18","author":"B Busser","year":"2010","unstructured":"Busser B, Sancey L, Josserand V, Niang C, Favrot MC, Coll JL, et al. Amphiregulin promotes BAX inhibition and resistance to gefitinib in non-small-cell lung cancers. Mol Ther. 2010;18:528\u201335.","journal-title":"Mol Ther"},{"key":"3850_CR32","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s13238-021-00855-6","volume":"13","author":"B Liu","year":"2022","unstructured":"Liu B, Duenas D, Zheng L, Reckamp K, Shen B. Genomic instability as a major mechanism for acquired resistance to EGFR tyrosine kinase inhibitors in cancer. Protein Cell. 2022;13:82\u20139.","journal-title":"Protein Cell"},{"key":"3850_CR33","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13000-016-0512-4","volume":"11","author":"L Wang","year":"2016","unstructured":"Wang L, Wu H, Wang L, Lu J, Duan H, Liu X, et al. Expression of amphiregulin predicts poor outcome in patients with pancreatic ductal adenocarcinoma. Diagn Pathol. 2016;11:60.","journal-title":"Diagn Pathol"},{"key":"3850_CR34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13046-016-0422-z","volume":"35","author":"J Gao","year":"2016","unstructured":"Gao J, Ulekleiv CH, Halstensen TS. Epidermal growth factor (EGF) receptor-ligand-based molecular staging predicts prognosis in head and neck squamous cell carcinoma partly due to deregulated EGF- induced amphiregulin expression. J Exp Clin Cancer Res. 2016;35:151.","journal-title":"J Exp Clin Cancer Res"},{"key":"3850_CR35","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/cam4.416","volume":"4","author":"SO Nam","year":"2015","unstructured":"Nam SO, Yotsumoto F, Miyata K, Fukagawa S, Yamada H, Kuroki M, et al. Warburg effect regulated by amphiregulin in the development of colorectal cancer. Cancer Med. 2015;4:575\u201387.","journal-title":"Cancer Med"},{"key":"3850_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2024.102274","volume":"35","author":"SJ Park","year":"2024","unstructured":"Park SJ, Park SJ, Kwon YW, Choi EH. Synergistic combination of RAD51-SCR7 improves CRISPR-Cas9 genome editing efficiency by preventing R-loop accumulation. Mol Ther Nucleic Acids. 2024;35:102274.","journal-title":"Mol Ther Nucleic Acids"},{"key":"3850_CR37","doi-asserted-by":"publisher","first-page":"102","DOI":"10.5483\/BMBRep.2022-0149","volume":"56","author":"SJ Park","year":"2023","unstructured":"Park SJ, Yoon S, Choi EH, Hyeon H, Lee K, Kim KP. Elevated expression of exogenous RAD51 enhances the CRISPR\/Cas9-mediated genome editing efficiency. BMB Rep. 2023;56:102\u20137.","journal-title":"BMB Rep"},{"key":"3850_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-022-02632-y","volume":"23","author":"EH Choi","year":"2022","unstructured":"Choi EH, Yoon S, Koh YE, Hong TK, Do JT, Lee BK, et al. Meiosis-specific cohesin complexes display essential and distinct roles in mitotic embryonic stem cell chromosomes. Genome Biol. 2022;23:70.","journal-title":"Genome Biol"},{"key":"3850_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-94533-w","volume":"15","author":"EH Choi","year":"2025","unstructured":"Choi EH, Kim KP. Cohesin and condensin regulate chromosome topology and play an essential role in maintaining pluripotency in embryonic stem cells. Sci Rep. 2025;15:9918.","journal-title":"Sci Rep"},{"key":"3850_CR40","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3390\/onco4040019","volume":"4","author":"C Guernsey-Biddle","year":"2024","unstructured":"Guernsey-Biddle C, High P, Carmon KS. Exploring the potential of epiregulin and amphiregulin as prognostic, predictive, and therapeutic targets in colorectal cancer. Onco. 2024;4:257\u201374.","journal-title":"Onco"},{"key":"3850_CR41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/jin2.39","volume":"3","author":"L Sasso","year":"2018","unstructured":"Sasso L, Purdie L, Grabowska A, Jones AT, Alexander C. Time and cell-dependent effects of endocytosis inhibitors on the internalization of biomolecule markers and nanomaterials. J Interdiscip Nanomed. 2018;3:67\u201381.","journal-title":"J Interdiscip Nanomed"},{"key":"3850_CR42","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1080\/10543401003618983","volume":"20","author":"J Wu","year":"2010","unstructured":"Wu J. Statistical inference for tumor growth inhibition T\/C ratio. J Biopharm Stat. 2010;20:954\u201364.","journal-title":"J Biopharm Stat"},{"key":"3850_CR43","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3109\/08977199209046413","volume":"7","author":"B Modrell","year":"1992","unstructured":"Modrell B, McDonald VL, Shoyab M. The interaction of amphiregulin with nuclei and putative nuclear localization sequence binding proteins. Growth Factors. 1992;7:305\u201314.","journal-title":"Growth Factors"},{"key":"3850_CR44","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.canlet.2018.01.080","volume":"420","author":"M Guerard","year":"2018","unstructured":"Guerard M, Robin T, Perron P, Hatat AS, David-Boudet L, Vanwonterghem L, et al. Nuclear translocation of IGF1R by intracellular amphiregulin contributes to the resistance of lung tumour cells to EGFR-TKI. Cancer Lett. 2018;420:146\u201355.","journal-title":"Cancer Lett"},{"key":"3850_CR45","doi-asserted-by":"publisher","first-page":"27149","DOI":"10.1016\/S0021-9258(18)47137-2","volume":"269","author":"GR Johnson","year":"1994","unstructured":"Johnson GR, Wong L. Heparan sulfate is essential to amphiregulin-induced mitogenic signaling by the epidermal growth factor receptor. J Biol Chem. 1994;269:27149\u201354.","journal-title":"J Biol Chem"},{"key":"3850_CR46","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00403-007-0809-y","volume":"300","author":"A Yoshida","year":"2008","unstructured":"Yoshida A, Kanno H, Watabe D, Akasaka T, Sawai T. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha. Arch Dermatol Res. 2008;300:37\u201345.","journal-title":"Arch Dermatol Res"},{"key":"3850_CR47","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3389\/fonc.2018.00474","volume":"8","author":"S Stintzing","year":"2018","unstructured":"Stintzing S, Ivanova B, Ricard I, Jung A, Kirchner T, Tannapfel A, et al. Amphiregulin (AREG) and epiregulin (EREG) gene expression as predictors for overall survival (OS) in oxaliplatin\/fluoropyrimidine plus bevacizumab-treated mCRC patients-analysis of the phase III AIO KRK-0207 trial. Front Oncol. 2018;8:474.","journal-title":"Front Oncol"},{"key":"3850_CR48","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s43556-023-00151-1","volume":"4","author":"A Sarapultsev","year":"2023","unstructured":"Sarapultsev A, Gusev E, Komelkova M, Utepova I, Luo S, Hu D. JAK-STAT signaling in inflammation and stress-related diseases: implications for therapeutic interventions. Mol Biomed. 2023;4:40.","journal-title":"Mol Biomed"},{"key":"3850_CR49","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/sj.bjc.6602941","volume":"94","author":"HW Lo","year":"2006","unstructured":"Lo HW, Hung MC. Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival. Br J Cancer. 2006;94:184\u20138.","journal-title":"Br J Cancer"},{"key":"3850_CR50","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.cels.2020.07.004","volume":"11","author":"AE Davies","year":"2020","unstructured":"Davies AE, Pargett M, Siebert S, Gillies TE, Choi Y, Tobin SJ, et al. Systems-level properties of EGFR-RAS-ERK signaling amplify local signals to generate dynamic gene expression heterogeneity. Cell Syst. 2020;11:161\u201375.e165.","journal-title":"Cell Syst"},{"key":"3850_CR51","doi-asserted-by":"crossref","unstructured":"Nakanishi T, Koma YI, Miyako S, Torigoe R, Yokoo H, Omori M, et al. AREG upregulation in cancer cells via direct interaction with cancer-associated fibroblasts promotes esophageal squamous cell carcinoma progression through EGFR-Erk\/p38 MAPK signaling. Cells. 2024;13:1733.","DOI":"10.3390\/cells13201733"},{"key":"3850_CR52","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/2211-5463.12407","volume":"8","author":"V Hosur","year":"2018","unstructured":"Hosur V, Farley ML, Burzenski LM, Shultz LD, Wiles MV. ADAM17 is essential for ectodomain shedding of the EGF-receptor ligand amphiregulin. FEBS Open Bio. 2018;8:702\u201310.","journal-title":"FEBS Open Bio"},{"key":"3850_CR53","doi-asserted-by":"crossref","unstructured":"Gnosa SP, Puig Blasco L, Piotrowski KB, Freiberg ML, Savickas S, Madsen DH et al. ADAM17-mediated EGFR ligand shedding directs macrophage-promoted cancer cell invasion. JCI Insight 2022;7:e155296.","DOI":"10.1172\/jci.insight.155296"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03850-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03850-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03850-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T22:03:10Z","timestamp":1783980190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03850-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":53,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2026,8,4]]}},"alternative-id":["3850"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03850-5","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"26 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}